biomedicina slovenica


pr=Clemons : 6

  1. Vardy J. L.; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J.; Bordeleau Louise; Tannock Ian
    A randomized, double-blind, placebo-controlled cross over trial of the effect on quality of life (QOL) of continuing dexamethasone beyond 24 hours following moderately emetogenic chemotherapy in women with breast cancer
    2011
  2. Vardy JL; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J; Bordeleau Louise; Goodwin Peter C; Tannock Ian
    A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
    2012
  3. Amir Eitan; Šeruga Boštjan; Freedman Orit; Clemons Mark
    Amenorrhoea, menopause, and endocrine therapy for breast cancer
    2009
  4. Amir Eitan; Ocaña Alberto; Freedman Orit; Clemons Mark; Šeruga Boštjan
    Dose-dense treatment for triple-negative breast cancer: chemotherapy
    2010
  5. Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Josse Robert; Clemons Mark
    Zoledronic acid for breast cancer therapy-induced bone loss: medical oncology
    2010
  6. Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Freedman Orit; Clemons Mark
    Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer
    2010


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics